TIAA CREF Investment Management LLC cut its position in Vitamin Shoppe, Inc (NYSE:VSI) by 4.2% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 97,631 shares of the specialty retailer’s stock after selling 4,278 shares during the period. TIAA CREF Investment Management LLC owned about 0.42% of Vitamin Shoppe worth $1,967,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Olstein Capital Management L.P. increased its stake in Vitamin Shoppe by 22.9% in the first quarter. Olstein Capital Management L.P. now owns 802,133 shares of the specialty retailer’s stock worth $16,163,000 after buying an additional 149,338 shares during the last quarter. State Street Corp raised its stake in Vitamin Shoppe by 6.8% in the fourth quarter. State Street Corp now owns 660,908 shares of the specialty retailer’s stock worth $15,700,000 after buying an additional 41,987 shares in the last quarter. Ameriprise Financial Inc. raised its stake in Vitamin Shoppe by 3.8% in the first quarter. Ameriprise Financial Inc. now owns 574,091 shares of the specialty retailer’s stock worth $11,568,000 after buying an additional 20,859 shares in the last quarter. Norges Bank purchased a new stake in Vitamin Shoppe during the fourth quarter worth about $6,444,000. Finally, Principal Financial Group Inc. raised its stake in Vitamin Shoppe by 3.7% in the first quarter. Principal Financial Group Inc. now owns 181,564 shares of the specialty retailer’s stock worth $3,659,000 after buying an additional 6,408 shares in the last quarter.

Get Vitamin Shoppe Inc alerts:

Shares of Vitamin Shoppe, Inc (NYSE:VSI) opened at 5.90 on Friday. The company’s market capitalization is $137.02 million. The company’s 50 day moving average is $9.75 and its 200 day moving average is $15.37. Vitamin Shoppe, Inc has a 12-month low of $5.75 and a 12-month high of $28.41.

Vitamin Shoppe (NYSE:VSI) last issued its earnings results on Wednesday, August 9th. The specialty retailer reported $0.23 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.39 by $0.16. Vitamin Shoppe had a positive return on equity of 8.33% and a negative net margin of 11.98%. The firm had revenue of $304.84 million during the quarter, compared to the consensus estimate of $314.74 million. During the same quarter in the prior year, the business earned $0.55 earnings per share. Vitamin Shoppe’s revenue for the quarter was down 8.4% on a year-over-year basis. Analysts expect that Vitamin Shoppe, Inc will post $0.82 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This piece was first posted by Community Financial News and is the sole property of of Community Financial News. If you are reading this piece on another website, it was copied illegally and reposted in violation of United States & international trademark & copyright law. The original version of this piece can be accessed at https://www.com-unik.info/2017/08/19/tiaa-cref-investment-management-llc-sells-4278-shares-of-vitamin-shoppe-inc-vsi-updated.html.

A number of equities research analysts have recently issued reports on the stock. Zacks Investment Research upgraded shares of Vitamin Shoppe from a “strong sell” rating to a “hold” rating in a report on Tuesday, July 18th. Goldman Sachs Group, Inc. (The) restated a “sell” rating and set a $6.00 price target (down previously from $13.00) on shares of Vitamin Shoppe in a report on Thursday, August 10th. TheStreet lowered shares of Vitamin Shoppe from a “c-” rating to a “d” rating in a report on Wednesday, August 9th. Morgan Stanley upgraded shares of Vitamin Shoppe from an “underweight” rating to an “equal weight” rating and set a $14.00 price objective on the stock in a research note on Thursday, May 11th. Finally, Deutsche Bank AG reiterated a “hold” rating and issued a $7.00 price objective (down previously from $14.00) on shares of Vitamin Shoppe in a research note on Thursday, August 10th. Three equities research analysts have rated the stock with a sell rating and seven have issued a hold rating to the company’s stock. The company has a consensus rating of “Hold” and an average price target of $15.71.

Vitamin Shoppe Company Profile

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

What are top analysts saying about Vitamin Shoppe Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Vitamin Shoppe Inc and related companies.